Editing Castrate-Resistant Prostate Cancer (section)

== Prognosis ==

* '''<span style="color:#ff0000">Prognostic factors (8):</span>'''[https://pubmed.ncbi.nlm.nih.gov/33556313/ §]
*# '''<span style="color:#ff0000">PSA'''
*# '''<span style="color:#ff0000">PSA doubling time'''
*# '''<span style="color:#ff0000">Performance status'''
*# '''<span style="color:#ff0000">Presence of visceral metastases'''
*# '''<span style="color:#ff0000">Presence of bone pain'''
*# '''<span style="color:#ff0000">Extent of disease on bone scan'''
*# '''<span style="color:#ff0000">Serum lactate dehydrogenase'''
*# '''<span style="color:#ff0000">Serum alkaline phosphatase'''
* '''<span style="color:#ff0000">PSA doubling time'''
** '''Associated with risk of progression to clinical metastases or death in patients with nmCRPC'''
** '''Predicts the rapidity of bone scan progression and survival''' [in patients with CRPC]
** '''<span style="color:#ff0000">PSADT < 3 months associated with a rapid clinical course and should possibly be considered for more aggressive management approaches'''